Awareness and interest in IQOS heated tobacco products among youth in Canada, England and the USA
- PMID: 30696783
- PMCID: PMC7958490
- DOI: 10.1136/tobaccocontrol-2018-054654
Awareness and interest in IQOS heated tobacco products among youth in Canada, England and the USA
Abstract
Introduction: Heated tobacco products (HTPs), such as IQOS, have been introduced in a growing number of international markets. However, little is known about perceptions of HTP products among youth.
Methods: Data are from wave 1 of the International Tobacco Control Youth Tobacco and E-cigarette Survey (2017), a web-based cohort survey of people aged 16-19 years from Canada, England and the USA. Respondents (n=12 064) were shown an image of IQOS and asked about their awareness, interest in trying and susceptibility to trying the product. Youth awareness, interest in trying and susceptibility to trying IQOS were analysed using descriptive statistics, and logistic regression models were used to examine correlates of these outcomes.
Results: Overall, 7.0% of youth reported awareness of IQOS (England=5.6%, Canada=6.4% and USA=9.1%) and 38.6% expressed interest in trying the product (England=41.8%, Canada=33.0% and USA=40.9%). Within each country, all key outcomes varied by smoking status: greater proportions of youth who were currently smoking or had a history of smoking reported being aware of, interested in trying and susceptible to trying IQOS. Interest and susceptibility to trying IQOS were associated with male sex, current tobacco use and current e-cigarette use. Across all countries, susceptibility to trying IQOS (25.1%) was higher than for tobacco cigarettes (19.3%), but lower than for e-cigarettes (29.1%).
Conclusions: Awareness of HTPs, such as IQOS, is emerging among youth in Canada, England and the USA. Interest in trying these products is very high among smokers, but also present among non-smokers.
Keywords: electronic nicotine delivery devices; prevention; public policy; surveillance and monitoring.
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: RJO is a member of the FDA’s Tobacco Products Scientific Advisory Committee which reviewed the IQOS MRTP application. Views expressed herein do not necessarily reflect those of the Committee or of the FDA. DH has provided paid testimony in tobacco litigation on behalf of governments and class-action plaintiffs on issues related to tobacco product science and regulation. The other authors have no competing interest relevant to this article to disclose.
Figures
References
-
- O’Connor RJ, Hyland A, Giovino GA, et al. Smoker awareness of and beliefs about supposedly less-harmful tobacco products. Am J Prev Med 2005;29(2):85–90. - PubMed
-
- Pollay RW, Dewhirst T. Marketing cigarettes with low machine measured yields. In: Shopland DR, Burns DM, Benowitz NL, Amacher HR, eds. Smoking and tobacco control monograph 13: Risks associated with smoking cigarettes with low machine-measured yields of tar and nicotine. Bethesda: United States (US) Department of Health and Human Services; 2001:199–233.
-
- U.S. Department of Health and Human Services. How tobacco smoke causes disease: The biology and behavioral basis for smoking-attributable disease. A report of the Surgeon General 2010. http://www.cdc.gov/tobacco/data_statistics/sgr/2010/. Accessed January 16, 2018. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical